G

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

Field Reimbursement Manager - Market Access, Mid-Atlantic Region

Full-TimeUpdated on 10/22/2026
$132k - $198k/yr+ Performance-based cash bonus(es) + Long-term incentives
Senior
Bachelor's
Remote in USA
RemoteRemote role covering the Mid-Atlantic; must live within the territory and travel up to 40%. Must live within the Mid-Atlantic region.
Customer Experience & SupportCustomer Education & Training
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree or equivalent is required.
  • At least 5 years of experience in the U.S. healthcare medical device or pharmaceutical sector is required.
  • At least 3 years of U.S. Field Reimbursement Manager experience is required.
  • Knowledge of and experience with medical benefit reimbursement and payment mechanisms, including medical coding, claims, and billing processes, are required.
  • Comprehensive knowledge of government and commercial coverage and reimbursement dynamics is required.
  • Familiarity with provider office and hospital outpatient department reimbursement, regulations, customers, and account-based planning is required.
  • Knowledge of the radiology authorization process, including HCPCS, CPT, and ICD-10 codes and associated regulations, is required.
  • Experience working with a hub or reimbursement call center is required.
  • The ability to collaborate closely with strategic partners and peers and lead collaborative initiatives is required.
  • Problem-solving and decision-making skills, including the ability to suggest alternatives and solutions, are required.
  • The ability to build customer relationships, identify and resolve access challenges, and manage complex projects is required.
  • The ability to operate independently and lead successfully in a matrix environment is required.
  • Strong organization, strategic thinking, and verbal and written presentation skills are required.
  • The ability to travel to connect with customers and field sales teams is required.
  • Competence with customer relationship management systems, PowerPoint, Excel, and Word is required.
  • The candidate must live within the Mid-Atlantic territory.
Responsibilities
  • Serve as the subject matter expert on reimbursement support programs, payer claim processes, and access issue resolution.
  • Develop and deliver onboarding and in-service presentations, in person and virtually, to new and existing customer accounts.
  • Educate prescribers, office staff, imagers, and other customers about the PDx portfolio's payer coverage policies, reimbursement processes, patient services, and benefit investigation.
  • Serve as the primary point of contact for resolving general and patient-specific access and reimbursement challenges by leveraging internal and external resources.
  • Develop access and reimbursement tools and guides, and disseminate approved content related to product coverage, claims processing, prior authorizations, and appeals.
  • Maintain ongoing communication with Market Access Account Executives and Sales to provide field intelligence and prioritize key accounts regarding account interactions.
  • Attend conferences to promote GE HealthCare's Patient Support Services.
Desired Qualifications
  • Certified Professional Coding certification.
  • Experience in radiopharmaceuticals, imaging, or diagnostics.
  • Product launch experience.
  • The ideal candidate will live in Baltimore, Maryland, or Washington, D.C.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11% and backlog reached a record $23.9 billion.
  • CareIntellect for Operations launched September 2026 with Duke Health and Queen's Health Systems.
  • CE mark and FDA progress for Photonova Spectra expand 2026-2027 commercial momentum.

What critics are saying

  • FDA logged multiple 2026 Class 2 recalls, including AW Server and telemetry systems.
  • Patient Care Solutions remained weak in Q2 2026; management is reviewing a sale.
  • SOFIE closes only after 2027 regulatory approvals; PET supply integration can slip badly.

What makes GE Healthcare unique

  • GE HealthCare combines imaging hardware, radiopharmaceuticals, and workflow software across hospitals.
  • Photonova Spectra and Vivid 2026 show premium innovation plus AI-enabled clinical automation.
  • SOFIE's 21 cyclotrons extend GE HealthCare into radiotracer manufacturing, not just scanners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Tuition Reimbursement
  • Relocation Assistance

Company News

Associated Press
Oct 20th, 2026
GE HealthCare launches five-institution global trial of StarGuide GX theranostics SPECT/CT system

GE HealthCare has launched a clinical evaluation program for StarGuide GX, its next-generation digital 4D SPECT/CT system. Five institutions across three continents will take part. They are Hadassah Medical Center and Rambam Health Care Campus in Israel, Mayo Clinic in the US, Oncopole Claudius Regaud in France, and Peking University First Hospital in China. Each will assess image quality, quantitative performance, dynamic imaging, and workflow, and give feedback to guide the system's development. StarGuide GX uses dual-sided cadmium zinc telluride detectors and a dual-collimator design meant to remove manual collimator changes. It also uses NVIDIA RTX accelerated computing for image reconstruction. The system received CE Mark in November 2025 and is on sale in select EU states. Its US Food and Drug Administration 510(k) clearance is pending.

Yahoo Finance
Oct 19th, 2026
GE HealthCare launches LOGIQ Focus ultrasound with AI tools, 26% faster scans

GE HealthCare has launched LOGIQ Focus, a new general imaging ultrasound system in its LOGIQ family. The company announced the product in Chicago on October 19, 2026. The system runs on cSound Architecture and pairs high-definition imaging with AI-enabled tools. One of them, Auto Preset Assistant, detects the anatomy being scanned and activates the matching preset, saving up to five clicks per exam. In a third-party study, 90% of participants rated its image quality as excellent. The system was 26% faster than the predicate system. LOGIQ Focus is 510(k) cleared and CE Marked. GE HealthCare expects it and several other new products to add 1% to 2% to revenue growth, following more than $5 billion in innovation investment since 2023.

Business Wire
Oct 5th, 2026
GE HealthCare to acquire SOFIE Biosciences for $945M to expand US radiopharmaceutical supply

GE HealthCare has agreed to acquire SOFIE Biosciences, a US-based contract manufacturer of PET radiopharmaceuticals, for $945 million in cash. The deal with seller Trilantic North America is expected to close in the first half of 2027, subject to regulatory approvals. SOFIE Biosciences operates 15 contract manufacturing sites with 21 cyclotrons across the US, plus a theranostics-focused development and manufacturing facility. The acquisition establishes GE HealthCare's presence in the time-critical "final mile" of US PET radiopharmaceutical supply. The PET radiopharmaceutical market is expanding rapidly with approximately 20 PET radiotracers and over 30 radiotherapeutics currently under development. SOFIE Biosciences' portfolio includes a Phase III FAPI asset for which GE HealthCare already holds non-US rights. GE HealthCare estimates the transaction will be accretive to revenue growth, earnings margin, and earnings per share in the first full year of ownership.

PR Newswire
Sep 30th, 2026
AsiaMedic first in ASEAN to deploy GE HealthCare's MR31 deep learning MRI platform

AsiaMedic has become the first site in ASEAN to implement MR31, GE HealthCare's latest generation MRI platform featuring deep learning technology. The Singapore-based imaging centre is among the earliest adopters in Asia Pacific. MR31 incorporates deep learning technologies that reduce scan times and enable detailed examinations across neurological, musculoskeletal and nerve imaging. Sonic DL for 3D delivers up to 12 times scan acceleration, reducing examination times across brain, spine, orthopaedic and body scans. The platform also supports high-quality prostate MRI imaging. AIR Recon DL Phase Correction provides improved visualisation of clinically significant lesions, whilst high-resolution T2-weighted imaging aids lesion localisation for prostate fusion biopsy planning. Shorter scan times mean reduced patient time in scanners and may help decrease repeat examinations caused by movement.

Associated Press
Sep 22nd, 2026
GE HealthCare raises quarterly dividend 14% to $0.04 per share for Q3 2026

GE HealthCare Technologies announced a 14% dividend increase for the third quarter of 2026. The company's board declared a cash dividend of $0.04 per share, up from the previous quarter. The dividend will be paid on 13 November 2026 to shareholders of record as of 23 October 2026. GE HealthCare is a global healthcare solutions provider specialising in medical technology, pharmaceutical diagnostics, and AI-enabled software solutions. The company operates a $20.6 billion business with approximately 54,000 employees worldwide, serving the healthcare industry through its Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions segments.